ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

An integrated model of the gross tumor volume of cervical lymph nodes and pretreatment plasma Epstein-Barr virus DNA predicts survival of nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a big-data intelligence platform-based analysis

Li, Jun Yan; Huang, Cheng Long; Luo, Wei Jie; Zhang, Yuan; Tang, Ling Long; Peng, Hao; Sun, Ying; Chen, Yu Pei*; Ma, Jun*中山大学
Therapeutic Advances in Medical Oncology2019-9DOI: 10.1177/1758835919877729
13阅读
引用收藏
分享

摘要

Background: Few studies have evaluated the prognostic value of the integrated model consisting of gross tumor volume of lymph nodes (GTVnd) and pretreatment plasma Epstein-Barr virus DNA (pre-EBV DNA) in nasopharyngeal carcinoma (NPC) patients. Methods: A well-established big-data intelligence platform with 10,126 NPC patients was used for a retrospective review. A total of 1500 cases with cervical nodal metastases but without distant metastases were randomly assigned to a training (n = 503) or test condition (n = 997) for analyses. The cut-off point for the GTVnd derived from the receiver operating characteristic (ROC) curve was combined with the published cut-off point for pre-EBV DNA to develop an integrated model by which patients were classified into four groups. Results: Both GTVnd and pre-EBV DNA were independent prognostic factors. Regardless of whether patients received induction chemotherapy (IC), the 5-year distant metastasis-free survival (DMFS) (69.5%) and overall survival (OS) (68.4%) were significantly worse in those with both a GTVnd >20 ml and pre-EBV DNA >2000 copies/ml (all p-values < 0.001). In patients with IC, all others had better 5-year DMFS and OS; in patients without IC, those with either a GTVnd >20 ml or pre-EBV DNA >2000 copies/ml had the medium 5-year DMFS and OS, while patients with neither of them had the best. Conclusions: The integrated GTVnd and pre-EBV DNA model not only predicted DMFS and OS in NPC patients effectively, but was an indicator of timely adjustment of therapeutic strategies for NPC patients, especially those completing IC.

学科与关键词

关键词
distant metastasis-free survivalgross tumor volume of lymph nodesnasopharyngeal carcinomaoverall survivalpretreatment plasma Epstein-Barr virus DNAprognostic model
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Therapeutic Advances in Medical Oncology
发表日期
2019-09
卷期
第 11 卷
页码
UNSP 1758835919877729
DOI
10.1177/1758835919877729
语言
ENGLISH
成果收录
CHINAJOURNAL · SCIE
资助标注
Natural Science Foundation of Guangdong ProvinceNational Natural Science Foundation of Guangdong Province [2017A030312003]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China [81802707]; Health and Medical Collaborative Innovation Project of Guangzhou City, China [201803040003]; Innovation Team Development Plan of the Ministry of Education [IRT_17R110]; Planned Science and Technology Project of Guangdong Province [2019B020230002]; Overseas Expertise Introduction Project for Discipline Innovation (111 Project) [B14035]

作者

  • L

    Li, Jun Yan (第一作者)

    sun yat sen univ

  • H

    Huang, Cheng Long

    sun yat sen univ

查看全部 9 位作者收起作者
  • L

    Luo, Wei Jie

    sun yat sen univ

  • Z

    Zhang, Yuan

    sun yat sen univ

  • T

    Tang, Ling Long

    sun yat sen univ

  • P

    Peng, Hao

    sun yat sen univ

  • S

    Sun, Ying

    sun yat sen univ

  • C

    Chen, Yu Pei (通讯)

    sun yat sen univ

  • M

    Ma, Jun (通讯)

    sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417